Skip to main content
SpringerLink
Log in

Diet and Drug Treatment of Gout

  • Conference paper
Genetic and Therapeutic Aspects of Lipid and Purine Metabolism

Abstract

The treatment of gout has two goals, immediate control of acute attacks of gouty arthritis and long-term control of hyperuricaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Band PR, Silverberg DS, Henderson JF, Ulan RA, Wensel RH, Banerjee TK, Little AS (1970) Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med 283:354

    Article  PubMed  CAS  Google Scholar 

  • Beardmore TD, Cashman JS, Kelley WN (1972) Mechanism of allopurinol mediated increase in enzyme activity in man. J Clin Invest 51:1823

    Article  PubMed  CAS  Google Scholar 

  • Berlinger WG, Park GD, Spector R (1985) The effect of dietary protein on the clearance of allopurinol and oxipurinol. N Engl J Med 313:771

    Article  PubMed  CAS  Google Scholar 

  • Colling M, Wolfram G (1987) Zum Einfluß des Garens auf den Puringehalt von Lebensmitteln. Z Ernährungswiss 26:214

    Article  PubMed  CAS  Google Scholar 

  • Elion GB (1966) Enzymatic and metabolic studies with allopurinol. Ann Rheum Dis 25:608

    PubMed  CAS  Google Scholar 

  • Elion GB, Yü TF, Gutman AB, Hitchings GH (1968) Renal clearance of oxipurinol, the chief metabolite of allopurinol. Am J Med 45:69

    Article  PubMed  CAS  Google Scholar 

  • Fox IJ, Wyngaarden JB, Kelley WN (1970) Depletion of erythrocyte phosphoribosylpyro-phosphate in man, a newly observed effect of allopurinol. N Engl J Med 283:1177

    Article  PubMed  CAS  Google Scholar 

  • Fox RM, Royse-Smith D, O’Sullivan WJ (1970) Orotidinuria induced by allopurinol. Science 168:861

    Article  PubMed  CAS  Google Scholar 

  • Gröbner W, Kelley WN (1975) Effect of allopurinol and its metabolic derivatives on the configuration of human orotate phosphoribosyltransferase and orotidine-5-phosphate decarboxylase. Biochem Pharmacol 24:379

    Article  PubMed  Google Scholar 

  • Gröbner W, Zöllner N (1976) Uricosurica. In: Zöllner N, Gröbner W (eds) Gicht. Springer, Berlin Heidelberg New York, p 491, (Handbuch der Inneren Medizin, vol 7/3)

    Google Scholar 

  • Gröbner W, Zöllner N (1983) Der Einfluß von Nahrungspurinen und-pyrimidinen auf die Pyrimidinsynthese des Menschen. Klin Wochenschr 61:1191

    Article  PubMed  Google Scholar 

  • Gutman AB, Yü TF (1952) Gout, a derangement of purine metabolism. Adv Intern Med 5:227

    PubMed  CAS  Google Scholar 

  • Löffler W (1982) Urikosurika. In: Zöllner N (ed) Therapie und Prognose von Hyperurikämie und Gicht. Springer, Berlin Heidelberg New York, p 73 (Hyperurikämie und Gicht, vol 5)

    Google Scholar 

  • Löffler W, Gröbner W (1988) A study of dose-response relationships of allopurinol in the presence of low or high purine turnover. Klin Wochenschr 66:153

    Article  PubMed  Google Scholar 

  • Löffler W, Gröbner W, Zöllner N (1983) Harnsäuresenkende Wirkung einer Kombination von Benzbromaron und Allopurinol-Untersuchungen unter standardisierten Ernährungsbedingungen. Arzneimittelforschung 33(11): 1687

    PubMed  Google Scholar 

  • Reiter S, Löffler W, Gröbner W, Zöllner N (1984) Influence of dietary purines on the metabolism of allopurinol in man. World Rev Nutr Diet 43:187

    PubMed  CAS  Google Scholar 

  • Rundles RW (1985) The development of allopurinol. Arch Intern Med 145:1492

    Article  PubMed  CAS  Google Scholar 

  • Rundles RW, Wyngaarden JB, Hitchings GH, Elion GB, Silberman HR (1963) Effects of xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout. Trans Assoc Am Physicians 76:126

    CAS  Google Scholar 

  • Seegmiller JE, Grayzel AJ (1960) Use of the newer uricosuric agents in the management of gout. JAMA 173:1076

    PubMed  CAS  Google Scholar 

  • Simmonds HA, Rising TJ, Cadenhead A, Hatfield PJ, Jones A, Cameron JS (1973) Radioisotope studies of purine metabolism during administration of guanine and allopurinol in the pig. Biochem Pharmacol 22:2553

    Article  CAS  Google Scholar 

  • Wyngaarden JB, Kelley WN (1983) “Gout”. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th edn. Mc Graw-Hill, New York, p 1043

    Google Scholar 

  • Yü TF, Gutman AB (1961) Efficacy of colchicine prophylaxis in gout. Ann Intern Med 55:179

    PubMed  Google Scholar 

  • Zöllner N (1975) Diet and gout. Nutrition 1:267

    Google Scholar 

  • Zöllner N, Gröbner W (1970) Der unterschiedliche Einfluß von Allopurinol auf die endogene und exogene Uratquote. Eur J Clin Pharmacol 3:56

    Article  Google Scholar 

  • Zöllner N, Gröbner W (1971) Influence of oral ribonucleic acid on orotaciduria due to allopurinol administration. Z Gesamte Exp Med 156:317

    Article  PubMed  Google Scholar 

  • Zöllner N, Gröbner W (1987) Purinstoffwechsel; Urikosurika, Urikostatika. Pharmakotherapie der Gicht. In: Forth W, Henschler D, Rummel W (eds) Allgemeine und spezielle Pharmakologie und Toxikologie. Wissenschaftsverlag, B. J., p 362

    Google Scholar 

  • Zöllner N, Griebsch A, Gröbner W (1972) Einfluß verschiedener Purine auf den Harnsäurestoffwechsel. Ernährungsumschau 3:79

    Google Scholar 

Download references

Authors
  1. W. Gröbner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Poliklinik der Universität, Pettenkoferstrasse 8a, 8000, München 2, Germany

    Günther Wolfram

  2. Institut für Ernährungswissenschaft in Weihenstephan, Technische Universität München, 8050, Freising, Germany

    Günther Wolfram

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gröbner, W. (1989). Diet and Drug Treatment of Gout. In: Wolfram, G. (eds) Genetic and Therapeutic Aspects of Lipid and Purine Metabolism. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61322-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-61322-7_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-50408-5

  • Online ISBN: 978-3-642-61322-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation